Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
M Cristina Pimenta
1
* , PhD ;
Thiago Silva Torres
1
* , PhD ;
Brenda Hoagland
1
, MD, PhD ;
Mirian Cohen
1
, PhD ;
Claudio Gruber Mann
1
, PhD ;
Cristina M Jalil
1
, MSc ;
Eduardo Carvalheira
1
, MSc ;
Lucilene Freitas
1
, PhD ;
Nilo Fernandes
1
, PhD ;
Debora Castanheira
1
, PhD ;
Marcos Benedetti
1
, MSc ;
Julio Moreira
2
, BA ;
Keila Simpson
3
, BA ;
Roberta Trefiglio
1
, BA ;
Gabrielle O’Malley
4
, PhD ;
Valdilea G Veloso
1
* , MD, PhD ;
Beatriz Grinsztejn
1
* , MD, PhD
1
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
2
Grupo Arco-Íris de Cidadania LGBT, Rio de Janeiro, Brazil
3
Associação Nacional de Travestis e Transexuais, Salvador, Brazil
4
Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA, United States
*these authors contributed equally
Corresponding Author:
-
Thiago Silva Torres, PhD
-
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz
-
Av Brasil 4365 Manguinhos
-
Rio de Janeiro, RJ 21040-900
-
Brazil
-
Phone:
55 21 38659623
-
Email: thiago.torres@ini.fiocruz.br